Feel free to talk to us!

508-713-0297
Breakthrough depression with Spravato treatment
Spravato logo
Spravato nasal spray

At Circle Integrative Psychiatry Group, we understand that combining multiple interventions is often crucial to achieving the most beneficial results for our clients. It is with great honor that we introduce Spravato®, a groundbreaking treatment option for individuals struggling with depression.

Spravato® is a revolutionary treatment option that can be used alongside oral antidepressants and must always be administered under the supervision of a healthcare provider. Studies have shown that this approach could yield significant results for individuals who have not responded to traditional antidepressant medications or talk therapy alone.

While it is not a cure for depression, Spravato® can provide substantial relief from symptoms and help clients regain their quality of life. If you or a loved one is struggling with depression, learn more about Spravato® and our other mental health treatment services. At Circle Integrative Psychiatry Group, our team of psychiatric and healthcare professionals is dedicated to supporting your journey to recovery.

What Is Spravato® Depression Treatment?

Spravato® is a transformative nasal spray depression treatment that contains esketamine. It works by resetting neural pathways in the brain and increasing levels of norepinephrine and serotonin, two neurotransmitters known to combat depression. This approach can lead to faster symptom relief than traditional oral antidepressants.

For individuals who have tried other depression treatments without success, Spravato® can be a welcome option. It is beneficial for those with treatment-resistant depression who struggle to respond to other forms of treatment or medications. It is important to note that this medication should be used as part of an overall recovery plan and should not replace the need for talk therapy or other lifestyle changes.

Approved Uses

Spravato® is indicated in the United States, in conjunction with an oral antidepressant, for treating adults with treatment-resistant depression (TRD) and for managing depressive symptoms in adults with MDD experiencing acute suicidal ideation or behavior.

The Spravato® Treatment Program at Circle Integrative Psychiatry Group

The Spravato® treatment program at Circle Integrative Psychiatry Group typically includes:

  • Initial evaluation and screening: An initial evaluation and screening process are required to determine if Spravato® treatment is suitable for you.
  • Educational session on the use of Spravato®: Our team of mental health professionals will provide an educational session to ensure you understand how to use Spravato®.
  • Administration of the medication: The medication will be administered in our office by a qualified healthcare professional.
  • Regular monitoring visits with a mental health professional: Regular monitoring visits will be scheduled to track your progress.
  • Ongoing therapeutic support: This is an important part of Spravato® treatment. Our team will work with you to create an individualized plan to help you manage your depression symptoms.

We understand that depression can make it challenging for individuals to take control of their lives, so our team of mental health professionals is there with you every step of the way, even during initial screening sessions, which may seem intimidating at first. With proper care, we believe each client has the potential to achieve true, lasting mental well-being.

Click here for Videos
SPRAVATO® ASK THE EXPERTS VIDEO: https://spravato.brightcovegallery.com/ask-the-expert

SPRAVATO® PATIENT VIDEO: NICOLE’S STORY: https://spravato.brightcovegallery.com/nicole-story

SPRAVATO® PATIENT VIDEO: ALLISON’S STORY: https://spravato.brightcovegallery.com/allison-social-sharing

SPRAVATO® PATIENT VIDEO: WHAT TO EXPECT DURING YOUR SPRAVATO® TREATMENT: https://spravato.brightcovegallery.com/spravato-patient-video

Do you have more questions for us? Please let us know by sending us a message or giving us a call.